Nanobiotix(法國(guó))

Nanobiotix

法國(guó)Nanobiotixwww.nanobiotix.comNanobiotix是一家納米醫(yī)藥公司，總部在法國(guó)巴黎，致力于開(kāi)發(fā)抗癌新藥。公司整合了納米科技與生物技術(shù)的優(yōu)勢(shì)。Nanobiotix衍生于布法羅的紐約州立大學(xué)，成立于2003年。其資金來(lái)源于幾家的歐洲風(fēng)投公司（MatignonInvestissement&Gestion、OTCAssetManagement、CapDecisifM anagement、AmorcageRhone-Alpes、CM-CICCapitalInnovation和MasseranGestion）。Nanobiotix已開(kāi)發(fā)出若干種新化合物，其目標(biāo)是提升自身在納米醫(yī)藥領(lǐng)域的地位。Nanobiotixisananomedicinecompanythatintendstorevolutionizecancertreatment.NanobiotixisfocusedonthedevelopmentofNanoXray,itsinnovativepipelinebasedonaphysicalmechanismofactionwithdepositofhighquantityofenergywithinthetumorcells.Nanobiotixiscommittedtoprovidepatientswithmeaningfullocalcancertreatment.NanoXrayproductsinteractwithradiotherapyimprovingthetumorcontrolusingtheexistingstandardradiationequipmentavailableinalmosteveryhospitalworld-wide.Radiationisastandardtherapyusedinthetreatmentofapproximately60%ofcancerpatients.Nanobiotixis